Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2890 participants.

Also called NCT05347069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 2,890 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05347069
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05347069. Randomized; no masking; primary purpose prevention. Start 2022-06-14 (actual); primary completion 2030-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Acronym
ASA-IN
Condition
Stable Angina Pectoris
Condition
Ischemic Heart Disease
Intervention (Drug)
Aspirin
Intervention (Drug)
No aspirin
Lead sponsor
Takeshi Morimoto (class: other)

Record details

Record id
cardio:ct-nct05347069
Content hash
712909c6513e318209ca6d2e4e0769dc22bcb647995912df69369af449b585ce